Correlation Between Artelo Biosciences and Altamira Therapeutics
Can any of the company-specific risk be diversified away by investing in both Artelo Biosciences and Altamira Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Artelo Biosciences and Altamira Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Artelo Biosciences and Altamira Therapeutics, you can compare the effects of market volatilities on Artelo Biosciences and Altamira Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Artelo Biosciences with a short position of Altamira Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Artelo Biosciences and Altamira Therapeutics.
Diversification Opportunities for Artelo Biosciences and Altamira Therapeutics
0.46 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Artelo and Altamira is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding Artelo Biosciences and Altamira Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Altamira Therapeutics and Artelo Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Artelo Biosciences are associated (or correlated) with Altamira Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Altamira Therapeutics has no effect on the direction of Artelo Biosciences i.e., Artelo Biosciences and Altamira Therapeutics go up and down completely randomly.
Pair Corralation between Artelo Biosciences and Altamira Therapeutics
Given the investment horizon of 90 days Artelo Biosciences is expected to generate 1.28 times more return on investment than Altamira Therapeutics. However, Artelo Biosciences is 1.28 times more volatile than Altamira Therapeutics. It trades about -0.06 of its potential returns per unit of risk. Altamira Therapeutics is currently generating about -0.16 per unit of risk. If you would invest 115.00 in Artelo Biosciences on September 1, 2024 and sell it today you would lose (12.00) from holding Artelo Biosciences or give up 10.43% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Artelo Biosciences vs. Altamira Therapeutics
Performance |
| Timeline |
| Artelo Biosciences |
| Altamira Therapeutics |
Artelo Biosciences and Altamira Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Artelo Biosciences and Altamira Therapeutics
The main advantage of trading using opposite Artelo Biosciences and Altamira Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Artelo Biosciences position performs unexpectedly, Altamira Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Altamira Therapeutics will offset losses from the drop in Altamira Therapeutics' long position.| Artelo Biosciences vs. Aileron Therapeutics | Artelo Biosciences vs. Histogen | Artelo Biosciences vs. Curis Inc | Artelo Biosciences vs. Salarius Pharmaceuticals |
| Altamira Therapeutics vs. Pyxis Oncology | Altamira Therapeutics vs. Zura Bio Limited | Altamira Therapeutics vs. Elevation Oncology | Altamira Therapeutics vs. Immix Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| CEOs Directory Screen CEOs from public companies around the world |